Login / Signup

Solar Energy-Based Future Perspective for Organic Rankine Cycle Applications.

Raúl Alejandro Martínez-SánchezJuvenal Rodríguez-ReséndizJosé Manuel Alvarez-AlvaradoIdalberto Macías-Socarrás
Published in: Micromachines (2022)
This article explores the patents of solar energy technologies in the organic Rankine cycle (ORC) applications. The conversion of low-quality thermal energy into electricity is one of the main characteristics of an ORC, making efficient and viable technologies available today. However, only a few and outdated articles that analyze patents that use solar energy technologies in ORC applications exist. This leads to a lack of updated information regarding the number of published patents, International Patent Classification (IPC) codes associated with them, technology life cycle status, and the most relevant patented developments. Thus, this article conducts a current investigation of patents published between January 2010 and May 2022 using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology and keywords. One thousand two hundred ninety-nine patents were obtained as part of the study and classified in F and Y groups of the IPC. The time-lapse analyzed was between January 2010 and May 2022. In 2014 and 2015, a peak of published patents was observed. China (CN) was the country that published the most significant number of patents worldwide. However, the European Patent Office (EP), the World Intellectual Property Organization (WO), and the United States (US) publish the patents with the highest number of patent citations. Furthermore, the possible trend regarding the development of patents for each technology is presented. A high-performance theoretical ORC plant based on the patent information analyzed by this article is introduced. Finally, exploration of IPC revealed 17 codes related to solar energy technologies in ORC applications not indexed in the main search.
Keyphrases
  • meta analyses
  • systematic review
  • randomized controlled trial
  • life cycle
  • squamous cell carcinoma
  • health information
  • adverse drug
  • quality improvement
  • electronic health record